Mechanisms of colon cancer chemoprevention by ursodeoxycholic acid
熊去氧胆酸化学预防结肠癌的机制
基本信息
- 批准号:8403901
- 负责人:
- 金额:$ 22.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-01-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAzoxymethaneBile AcidsCAV1 geneCancer EtiologyCaveolaeCell membraneCellsCessation of lifeChemopreventive AgentCholesterolClathrinClinical TrialsColon CarcinomaColonic NeoplasmsColonic PolypsColorectal NeoplasmsDevelopmentDiagnosisDiseaseDisease ProgressionEarly InterventionEffectivenessEndocytosisEpidermal Growth Factor ReceptorEventGrowthLaboratoriesLifeMalignant NeoplasmsMalignant neoplasm of lungMediatingMembraneMusPatientsPhase II Clinical TrialsPhosphorylationPreventionPrevention strategyPropertyProteinsResearchSignal PathwaySignal TransductionStructureTestingUbiquitinationUnited StatesUrsodeoxycholic Acidbasecancer chemopreventioncoated pitpublic health relevancereceptorresponseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant):
The hypothesis that will be tested suggests that ursodeoxycholic acid (UDCA) functions as a chemopreventive agent through the suppression of receptor-initiated mitogenic signaling by promoting receptor degradation. UDCA is one of several bile acids which are polar derivatives of cholesterol that can modulate the activity of a variety of cancer related interacellular signaling pathways. Recent studies from our laboratory indicate that the initial events in signal activation by bile acids take place at the plasma membrane and may involve membrane domains known as caveolae and clathrin coated pits. Both of these membrane structures are known to be involved in silencing of activated receptors through endocytosis which is followed by ubiquitination by c-Cbl and degradation. Our most recent evidence suggests that UDCA enhances degradation of EGFR and that UDCA-induced growth suppression is enhanced in the presence of caveolin1, a principal protein component of caveolae. Together these observations suggest that the cell membrane is a likely target for this bile acid and that UDCA may act by suppressing the proliferative capacity of cells. To test this we will conduct the following studies: (1) Test the hypothesis that UDCA-mediated degradation of EGFR involves relocalization to caveolae and clathrin coated pits, and (2) Test whether UDCA can function as a chemopreventive agent in mice that lack caveolin1.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JESSE D. MARTINEZ其他文献
JESSE D. MARTINEZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JESSE D. MARTINEZ', 18)}}的其他基金
(PQA 2) Obesity & Obstructive Sleep Apnea in Hepatocellular Carcinoma Progression
(PQA 2) 肥胖
- 批准号:
8686225 - 财政年份:2014
- 资助金额:
$ 22.69万 - 项目类别:
(PQA 2) Obesity & Obstructive Sleep Apnea in Hepatocellular Carcinoma Progression
(PQA 2) 肥胖
- 批准号:
8856183 - 财政年份:2014
- 资助金额:
$ 22.69万 - 项目类别:
Mechanisms of colon cancer chemoprevention by ursodeoxycholic acid
熊去氧胆酸化学预防结肠癌的机制
- 批准号:
8204971 - 财政年份:2010
- 资助金额:
$ 22.69万 - 项目类别:
Mechanisms of colon cancer chemoprevention by ursodeoxycholic acid
熊去氧胆酸化学预防结肠癌的机制
- 批准号:
8601360 - 财政年份:2010
- 资助金额:
$ 22.69万 - 项目类别:
Mechanisms of colon cancer chemoprevention by ursodeoxycholic acid
熊去氧胆酸化学预防结肠癌的机制
- 批准号:
8011237 - 财政年份:2010
- 资助金额:
$ 22.69万 - 项目类别:
Mechanisms of colon cancer chemoprevention by ursodeoxycholic acid
熊去氧胆酸化学预防结肠癌的机制
- 批准号:
7781680 - 财政年份:2010
- 资助金额:
$ 22.69万 - 项目类别:
Mechanisms of colon cancer chemoprevention by ursodeoxycholic acid
熊去氧胆酸化学预防结肠癌的机制
- 批准号:
8538003 - 财政年份:2010
- 资助金额:
$ 22.69万 - 项目类别:
The Role of p53 and 14-3-3 in Genomic Instability
p53 和 14-3-3 在基因组不稳定性中的作用
- 批准号:
7197980 - 财政年份:2004
- 资助金额:
$ 22.69万 - 项目类别:
The Role of p53 and 14-3-3 in Genomic Instability
p53 和 14-3-3 在基因组不稳定性中的作用
- 批准号:
7033879 - 财政年份:2004
- 资助金额:
$ 22.69万 - 项目类别:
相似海外基金
Effect of sulforaphane on radiation-induced colon tumorigenesis in azoxymethane-treated mice.
萝卜硫素对氧化偶氮甲烷治疗小鼠辐射诱导的结肠肿瘤发生的影响。
- 批准号:
24501000 - 财政年份:2012
- 资助金额:
$ 22.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dietary saturated fatty acid n-6 poly-unsaturated fatty acid accelerate azoxymethane induced colon carcinogenesis through up-regulation of Wnt/beta-catenin signaling
膳食饱和脂肪酸 n-6 多不饱和脂肪酸通过上调 Wnt/β-catenin 信号传导加速氧化偶氮甲烷诱导的结肠癌发生
- 批准号:
16590605 - 财政年份:2004
- 资助金额:
$ 22.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Long-term oil ingestion promotes invasive colon cancer by inhibiting in azoxymethane-treated rats
长期摄入石油通过抑制氧化偶氮甲烷治疗的大鼠促进侵袭性结肠癌
- 批准号:
15590658 - 财政年份:2003
- 资助金额:
$ 22.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CHEMPREVENTION OF AZOXYMETHANE-INDUCED COLON CANCER IN
化学预防偶氮甲烷诱发的结肠癌
- 批准号:
3617828 - 财政年份:1992
- 资助金额:
$ 22.69万 - 项目类别:
CHEMOPREVENTION OF AZOXYMETHANE-INDUCED FOCI OF ABERRANT
偶氮甲烷引起的异常病灶的化学预防
- 批准号:
3622183 - 财政年份:1992
- 资助金额:
$ 22.69万 - 项目类别:
CHEMPREVENTION OF AZOXYMETHANE-INDUCED COLON CANCER
氧化氮甲烷诱发的结肠癌的化学预防
- 批准号:
3617829 - 财政年份:1992
- 资助金额:
$ 22.69万 - 项目类别: